Joel J Davis

Summary

Affiliation: San Diego State University
Country: USA

Publications

  1. ncbi Riskier than we think? The relationship between risk statement completeness and perceptions of direct to consumer advertised prescription drugs
    J J Davis
    School of Communication, San Diego State University, San Diego, CA 92182 4561, USA
    J Health Commun 5:349-69. 2000
  2. ncbi Disenfranchising the disabled: the inaccessibility of Internet-based health information
    Joel J Davis
    School of Communication, San Diego State University, California 92182 4516, USA
    J Health Commun 7:355-67. 2002
  3. ncbi Pharmaceutical websites and the communication of risk information
    Joel J Davis
    School of Communication, San Diego State University, San Diego, California 92182, USA
    J Health Commun 12:29-39. 2007
  4. ncbi Consumers' preferences for the communication of risk information in drug advertising
    Joel J Davis
    San Diego State University, San Diego, California, USA
    Health Aff (Millwood) 26:863-70. 2007
  5. ncbi The effect of qualifying language on perceptions of drug appeal, drug experience, and estimates of side-effect incidence in DTC advertising
    Joel Davis
    School of Journalism and Media Studies, San Diego State University, San Diego, California 92182 4561, USA
    J Health Commun 12:607-22. 2007

Detail Information

Publications5

  1. ncbi Riskier than we think? The relationship between risk statement completeness and perceptions of direct to consumer advertised prescription drugs
    J J Davis
    School of Communication, San Diego State University, San Diego, CA 92182 4561, USA
    J Health Commun 5:349-69. 2000
    ..Implications of the research for the regulation and presentation of DTC prescription drug advertising and advertiser communication practices are discussed...
  2. ncbi Disenfranchising the disabled: the inaccessibility of Internet-based health information
    Joel J Davis
    School of Communication, San Diego State University, California 92182 4516, USA
    J Health Commun 7:355-67. 2002
    ..Analyses of reasons why home pages were inaccessible indicate that accessibility could be improved if recommended design and coding changes are implemented...
  3. ncbi Pharmaceutical websites and the communication of risk information
    Joel J Davis
    School of Communication, San Diego State University, San Diego, California 92182, USA
    J Health Commun 12:29-39. 2007
    ..For drugs with side effects at >or= 10% incidence, only about half of their websites fully reported all effects at this level of incidence. Implications for advertisers and regulatory agencies are presented...
  4. ncbi Consumers' preferences for the communication of risk information in drug advertising
    Joel J Davis
    San Diego State University, San Diego, California, USA
    Health Aff (Millwood) 26:863-70. 2007
    ..Consumers prefer detailed, readily accessible risk information--preferences that are a major departure from current advertiser practices and from what current and proposed Food and Drug Administration (FDA) regulations require...
  5. ncbi The effect of qualifying language on perceptions of drug appeal, drug experience, and estimates of side-effect incidence in DTC advertising
    Joel Davis
    School of Journalism and Media Studies, San Diego State University, San Diego, California 92182 4561, USA
    J Health Commun 12:607-22. 2007
    ..Policy implications of the research, particularly for evaluation of "fair balance" and the reporting of side effects, are presented...